RRM2 short interfering ribonucleic acid (RNA) delivery effectively decreased the proliferation of RA fibroblast-like synoviocytes (RA-FLS) and inhibited the secretion of tumor necrosis factor (TNF)-α and interleukin (IL)-6 [13]. The gene discussed is IL6; the disease is rheumatoid arthritis.